Sensitivity analysis of dose-response model parameters for the bladder in prostate cancer radiotherapy.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
1808 patients were analyzed for five late bladder toxicities.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
EQD2 α/β showed variable effects, large for cylindrical and small for spherical coordinates, while the number of permutations had only a small effect. [CONCLUSIONS] Parameter selection significantly influences high-risk subregion identification in DRMs, emphasizing the need for standardized parameter reporting for meaningful external comparisons.
[INTRODUCTION] This study evaluates how model parameter values affect dose-response maps (DRMs) in identifying high-risk bladder subregions associated with late urinary toxicities in prostate cancer p
- 표본수 (n) 763
APA
Puri T, Rancati T, et al. (2025). Sensitivity analysis of dose-response model parameters for the bladder in prostate cancer radiotherapy.. Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 139, 105178. https://doi.org/10.1016/j.ejmp.2025.105178
MLA
Puri T, et al.. "Sensitivity analysis of dose-response model parameters for the bladder in prostate cancer radiotherapy.." Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), vol. 139, 2025, pp. 105178.
PMID
41072101 ↗
Abstract 한글 요약
[INTRODUCTION] This study evaluates how model parameter values affect dose-response maps (DRMs) in identifying high-risk bladder subregions associated with late urinary toxicities in prostate cancer patients post-radiotherapy.
[METHODS] Data from 1808 patients were analyzed for five late bladder toxicities. Baseline scores were subtracted from maximum toxicity at 12 and 24 months and dichotomized into grades ≥ 1 and ≥ 2. Bladders were segmented on computed tomography scans, and dose-surface maps (DSMs) were created on 91 × 90 voxel grids using spherical and cylindrical coordinates. Voxel doses were converted to equivalent dose in 2 Gy fractions (EQD2, α/β 1-3 Gy). Welch's t and Mann-Whitney U equations were applied at each voxel location. Multiple comparisons were corrected via permutation testing (10-10000 iterations), and statistically significant voxels were identified using the 90th and 95th percentiles of Tmax/Umax. Sensitivity of parameters was assessed by varying one parameter at a time, with changes > 400 voxels (∼5% of 8190) classified as large and ≤ 400 as small.
[RESULTS] Urinary tract obstruction was the only toxicity significantly associated with bladder DSMs, focusing results on this outcome. After baseline adjustment and dichotomization, event/nonevent counts were 62/701 (grade≥1) and 21/742 (grade≥2; N = 763). DRM results showed large effects of toxicity grade threshold, coordinate system, statistical test equation, and Tmax/Umax thresholding. EQD2 α/β showed variable effects, large for cylindrical and small for spherical coordinates, while the number of permutations had only a small effect.
[CONCLUSIONS] Parameter selection significantly influences high-risk subregion identification in DRMs, emphasizing the need for standardized parameter reporting for meaningful external comparisons.
[METHODS] Data from 1808 patients were analyzed for five late bladder toxicities. Baseline scores were subtracted from maximum toxicity at 12 and 24 months and dichotomized into grades ≥ 1 and ≥ 2. Bladders were segmented on computed tomography scans, and dose-surface maps (DSMs) were created on 91 × 90 voxel grids using spherical and cylindrical coordinates. Voxel doses were converted to equivalent dose in 2 Gy fractions (EQD2, α/β 1-3 Gy). Welch's t and Mann-Whitney U equations were applied at each voxel location. Multiple comparisons were corrected via permutation testing (10-10000 iterations), and statistically significant voxels were identified using the 90th and 95th percentiles of Tmax/Umax. Sensitivity of parameters was assessed by varying one parameter at a time, with changes > 400 voxels (∼5% of 8190) classified as large and ≤ 400 as small.
[RESULTS] Urinary tract obstruction was the only toxicity significantly associated with bladder DSMs, focusing results on this outcome. After baseline adjustment and dichotomization, event/nonevent counts were 62/701 (grade≥1) and 21/742 (grade≥2; N = 763). DRM results showed large effects of toxicity grade threshold, coordinate system, statistical test equation, and Tmax/Umax thresholding. EQD2 α/β showed variable effects, large for cylindrical and small for spherical coordinates, while the number of permutations had only a small effect.
[CONCLUSIONS] Parameter selection significantly influences high-risk subregion identification in DRMs, emphasizing the need for standardized parameter reporting for meaningful external comparisons.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Male
- Prostatic Neoplasms
- Urinary Bladder
- Dose-Response Relationship
- Radiation
- Radiotherapy Dosage
- Aged
- Models
- Biological
- Tomography
- X-Ray Computed
- Middle Aged
- Bladder
- IBDM
- Image-based data mining
- Imaging biomarker
- Multicenter clinical trial
- OAR
- Organ-at-risk
- Prediction model
- Predictive modeling
- Prostate cancer
- Radiotherapy
… 외 4개
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.